You are hereBiblio / Ethics, Evidence, and Cost in Newborn Screening
Ethics, Evidence, and Cost in Newborn Screening
| Title | Ethics, Evidence, and Cost in Newborn Screening |
| Publication Type | Journal Article |
| Year of Publication | 2008 |
| Authors | Baily, Mary Ann, and Murray Thomas H. |
| Journal | Hastings Center Report |
| Volume | 38 |
| Issue | 3 |
| Pagination | 23-31 |
| Type of Article | Article |
| Publication Language | eng |
| ISSN Number | 00930334 |
| Accession Number | 32727113 |
| Keywords | BIOETHICS , EVIDENCE-based , Medical , MEDICINE , National , NEWBORN , United |
| Abstract | The article explores ethical and policy issues that arise in debates about public newborn screening programs in the U.S. It provides an overview of newborn screening and discusses requirements for ethical newborn screening policy. According to the article, there are four clauses included in the Hastings Center project funded by the National Human Genome Research Institute about newborn screening: newborn screening policy should be evidence-based, it should take opportunity cost into account, it should distribute the costs and benefits of the program fairly, and it should respect human rights. |
| Notes | Baily, Mary Ann Murray, Thomas H.; Source Info: May/Jun2008, Vol. 38 Issue 3, p23; Subject Term: NEWBORN infants -- Medical examinations; Subject Term: MEDICAL screening; Subject Term: MEDICAL policy; Subject Term: EVIDENCE-based medicine; Subject Term: MEDICAL ethics; Subject Term: UNITED States; Company/Entity: NATIONAL Human Genome Research Institute (U.S.); NAICS/Industry Codes: 621999 All Other Miscellaneous Ambulatory Health Care Services; Number of Pages: 9p; Document Type: Article |
| DOI | 10.1353/hcr.0.0009 |

